» Articles » PMID: 6416349

The End of Clinical Freedom

Overview
Specialty General Medicine
Date 1983 Oct 29
PMID 6416349
Citations 38
Authors
Affiliations
Soon will be listed here.
Citing Articles

Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists.

Raine T, Gkini M, Irving P, Kaul A, Korendowych E, Laws P BioDrugs. 2021; 35(2):187-199.

PMID: 33635522 PMC: 7952361. DOI: 10.1007/s40259-020-00464-5.


The Chiropractic Vertebral Subluxation Part 5: The First Research Era From 1928 to 1949.

Senzon S J Chiropr Humanit. 2019; 25:67-85.

PMID: 31019421 PMC: 6472114. DOI: 10.1016/j.echu.2018.10.004.


Evidence-based medicine: is it a bridge too far?.

Fernandez A, Sturmberg J, Lukersmith S, Madden R, Torkfar G, Colagiuri R Health Res Policy Syst. 2015; 13:66.

PMID: 26546273 PMC: 4636779. DOI: 10.1186/s12961-015-0057-0.


Therapeutic fashion and publication bias: the case of anti-arrhythmic drugs in heart attack.

Hampton J J R Soc Med. 2015; 108(10):418-20.

PMID: 26459066 PMC: 4622276. DOI: 10.1177/0141076815608562.


Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients.

Sacristan J BMC Med Inform Decis Mak. 2013; 13:6.

PMID: 23294526 PMC: 3575265. DOI: 10.1186/1472-6947-13-6.


References
1.
Wilcox R, Rowley J, Hampton J, Mitchell J, Roland J, Banks D . Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet. 1980; 2(8198):765-9. DOI: 10.1016/s0140-6736(80)90385-2. View

2.
Chamberlain D, Jewitt D, Julian D, CAMPBELL R, Boyle D, Shanks R . Oral mexiletine in high-risk patients after myocardial infarction. Lancet. 1980; 2(8208-8209):1324-7. DOI: 10.1016/s0140-6736(80)92395-8. View

3.
Phillips S, Zeff R, Kongtahworn C, Skinner J, Iannone L, Brown T . Surgery for evolving myocardial infarction. JAMA. 1982; 248(11):1325-8. View

4.
Hugenholtz P, Rentrop P . Thrombolytic therapy for acute myocardial infarction: quo vadis? A review of the recent literature. Eur Heart J. 1982; 3(5):395-403. DOI: 10.1093/oxfordjournals.eurheartj.a061325. View

5.
Khaja F, Walton Jr J, Brymer J, Lo E, Osterberger L, ONeill W . Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med. 1983; 308(22):1305-11. DOI: 10.1056/NEJM198306023082201. View